Volgen
Vamsidhar Velcheti MD FACP FCCP
Vamsidhar Velcheti MD FACP FCCP
Geverifieerd e-mailadres voor yale.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Programmed death ligand-1 expression in non-small cell lung cancer
V Velcheti, KA Schalper, DE Carvajal, VK Anagnostou, KN Syrigos, ...
Laboratory investigation 94 (1), 107-116, 2014
8372014
Quantitative assessment of the heterogeneity of PD-L1 expression in non–small-cell lung cancer
J McLaughlin, G Han, KA Schalper, D Carvajal-Hausdorf, V Pelekanou, ...
JAMA oncology 2 (1), 46-54, 2016
7252016
Artificial intelligence in digital pathology—new tools for diagnosis and precision oncology
K Bera, KA Schalper, DL Rimm, V Velcheti, A Madabhushi
Nature reviews Clinical oncology 16 (11), 703-715, 2019
5172019
In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast CarcinomasPD-L1 mRNA Positivity and Outcome in Breast Cancer
KA Schalper, V Velcheti, D Carvajal, H Wimberly, J Brown, L Pusztai, ...
Clinical Cancer Research 20 (10), 2773-2782, 2014
4622014
Sotorasib for Lung Cancers with KRAS p.G12C Mutation
F Skoulidis, BT Li, GK Dy, TJ Price, GS Falchook, J Wolf, A Italiano, ...
New England Journal of Medicine 384 (25), 2371-2381, 2021
3672021
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
A Drilon, GR Oxnard, DSW Tan, HHF Loong, M Johnson, J Gainor, ...
New England Journal of Medicine 383 (9), 813-824, 2020
3522020
Objective measurement and clinical significance of TILs in non–small cell lung cancer
KA Schalper, J Brown, D Carvajal-Hausdorf, J McLaughlin, V Velcheti, ...
Journal of the National Cancer Institute 107 (3), dju435, 2015
3292015
Radiomics and radiogenomics in lung cancer: a review for the clinician
R Thawani, M McLane, N Beig, S Ghose, P Prasanna, V Velcheti, ...
Lung cancer 115, 34-41, 2018
3222018
Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials
M Khunger, S Rakshit, V Pasupuleti, AV Hernandez, P Mazzone, ...
Chest 152 (2), 271-281, 2017
3222017
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
JM Wrangle, V Velcheti, MR Patel, E Garrett-Mayer, EG Hill, JG Ravenel, ...
The Lancet Oncology 19 (5), 694-704, 2018
2772018
Targeting RET in patients with RET-rearranged lung cancers: results from the global, multicenter RET registry
O Gautschi, J Milia, T Filleron, J Wolf, DP Carbone, D Owen, R Camidge, ...
Journal of Clinical Oncology 35 (13), 1403, 2017
2722017
Selective RET kinase inhibition for patients with RET-altered cancers
V Subbiah, V Velcheti, BB Tuch, K Ebata, NL Busaidy, ME Cabanillas, ...
Annals of Oncology 29 (8), 1869-1876, 2018
2572018
Perinodular and intranodular radiomic features on lung CT images distinguish adenocarcinomas from granulomas
N Beig, M Khorrami, M Alilou, P Prasanna, N Braman, M Orooji, S Rakshit, ...
Radiology 290 (3), 783, 2019
1872019
Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma
M Vassilakopoulou, M Avgeris, V Velcheti, V Kotoula, T Rampias, ...
Clinical Cancer Research 22 (3), 704-713, 2016
1742016
Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity
C Calabrese, E Kirchner, A Kontzias, V Velcheti, LH Calabrese
RMD open 3 (1), e000412, 2017
1662017
Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1)
V Velcheti, DL Rimm, KA Schalper
Journal of thoracic oncology 8 (6), 803-805, 2013
1482013
Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung CancerPD-L1, IDO-1, and B7-H4 in NSCLC
KA Schalper, D Carvajal-Hausdorf, J McLaughlin, M Altan, V Velcheti, ...
Clinical Cancer Research 23 (2), 370-378, 2017
1472017
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell AnalysisPD-1, LAG-3 …
I Datar, MF Sanmamed, J Wang, BS Henick, J Choi, T Badri, W Dong, ...
Clinical Cancer Research 25 (15), 4663-4673, 2019
1462019
Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non–small cell lung cancer
G Corredor, X Wang, Y Zhou, C Lu, P Fu, K Syrigos, DL Rimm, M Yang, ...
Clinical cancer research 25 (5), 1526-1534, 2019
1452019
Rational design of anti-GITR-based combination immunotherapy
R Zappasodi, C Sirard, Y Li, S Budhu, M Abu-Akeel, C Liu, X Yang, ...
Nature medicine 25 (5), 759-766, 2019
1422019
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20